Associations of circulating biomarkers with the presence and severity of coronary, carotid and femoral arterial atherosclerosis
Open Access
- 8 January 2022
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8), 3098
- https://doi.org/10.15829/1728-8800-2021-3098
Abstract
Aim. To identify and characterize the associations of the presence and severity of atherosclerosis of various localization with the blood level of biochemical parameters, as well as to assess the potential of their use as markers of metabolic disorders with increased atherogenic potential.Material and methods. The study included 216 patients (men, 53%) aged 24-87 years (mean age, 61,5±10,73 years). All patients underwent coronary angiography, carotid (CA) and femoral arterial (FA) duplex ultrasound to assess the presence and severity of atherosclerosis. In blood serum/plasma, biochemical parameters were analyzed using standard methods.Results. Based on the analysis of circulating biomarker profile, diagnostic complexes have been established that allow assessing atherosclerosis of different localization. According to the data obtained, the determinants of coronary and CA atherosclerosis are endothelial dysfunction (concentration of nitric oxide metabolites Conclusion. The analysis of associations of circulating biochemical parameters with atherosclerosis localization and severity revealed a number of metabolic markers associated with the increased atherogenic potential. It is possible to distinguish both universal parameters that are associated with atherosclerosis, regardless of its localization and/or severity, and specific biomarkers that characterize either the localization or the severity of atherosclerosis, or both.Keywords
This publication has 27 references indexed in Scilit:
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)European Journal of Preventive Cardiology, 2012
- Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive surveyDrug Design, Development and Therapy, 2011
- Biospecimen Reporting for Improved Study QualityBiopreservation and Biobanking, 2011
- The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2007
- The Prevalence of Peripheral Arterial Disease in High Risk Subjects and Coronary or Cerebrovascular PatientsAngiology, 2007
- The United States Preventive Services Task Force Recommendation Statement on Screening for Peripheral Arterial DiseaseJournal of the American College of Cardiology, 2006
- Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)Journal of the American College of Cardiology, 2005
- Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*Journal of Hypertension, 2005
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesJournal of the American College of Cardiology, 2004
- Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up studyJournal of Clinical Epidemiology, 2004